🔗 Share this article

The top legal official in Texas Paxton is suing the makers of Tylenol, alleging the companies withheld potential risks that the pain reliever created to children's brain development.

The lawsuit follows four weeks after President Donald Trump publicized an unsubstantiated connection between consuming Tylenol - referred to as paracetamol - throughout gestation and autism in offspring.

Paxton is filing suit against the pharmaceutical giant, which previously sold the medication, the exclusive pain medication suggested for pregnant women, and the current manufacturer, which now manufacturers it.

In a official comment, he said they "deceived the public by gaining financially from suffering and promoting medication ignoring the risks."

The company states there is no credible evidence tying acetaminophen to autism spectrum disorder.

"These manufacturers lied for decades, intentionally threatening numerous people to increase profits," Paxton, a Republican, said.

Kenvue said in a statement that it was "very worried by the dissemination of inaccurate information on the reliability of acetaminophen and the possible consequences that could have on the health of US mothers and children."

On its official site, Kenvue also stated it had "consistently assessed the pertinent research and there is lacking reliable evidence that shows a established connection between taking acetaminophen and autism."

Groups representing physicians and healthcare providers share this view.

The leading OB-GYN organization has stated acetaminophen - the primary component in Tylenol - is a restricted selection for expectant mothers to treat pain and fever, which can create major wellness concerns if ignored.

"In more than two decades of investigation on the use of acetaminophen in pregnancy, not a single reputable study has successfully concluded that the usage of acetaminophen in any trimester of pregnancy results in neurodevelopmental disorders in young ones," the organization said.

The lawsuit cites latest statements from the Trump administration in asserting the medication is allegedly unsafe.

In recent weeks, Trump caused concern from medical authorities when he advised pregnant women to "fight like hell" not to use acetaminophen when unwell.

The US Food and Drug Administration then issued a notice that doctors should contemplate reducing the consumption of Tylenol, while also declaring that "a causal relationship" between the drug and autism in young ones has not been established.

The Health Department head Kennedy, who supervises the FDA, had pledged in spring to conduct "a massive testing and research effort" that would establish the origin of autism in a limited time.

But authorities advised that finding a single cause of autism - considered by experts to be the result of a complicated interplay of inherited and external influences - would not be simple.

Autism spectrum disorder is a type of permanent neurological difference and condition that influences how persons experience and engage with the world, and is identified using physician assessments.

In his lawsuit, Paxton - aligned with the former president who is running for the Senate - claims Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the research" around acetaminophen and autism spectrum disorder.

The lawsuit attempts to require the companies "eliminate any marketing or advertising" that asserts Tylenol is secure for pregnant women.

The Texas lawsuit mirrors the complaints of a collection of parents of children with autism and ADHD who sued the makers of acetaminophen in 2022.

A federal judge dismissed the case, saying studies from the family's specialists was inconclusive.